The McPherson Eye Research Institute is pleased to announce the winners of our inaugural Grant Accelerator Program (GAP) award competition! Supported by the Alice McPherson Endowment Fund for the Visual Sciences, the Van Vreede McPherson ERI Greatest …
Year: 2025
Researchers ‘seq’ and find a way to make pig retinal cells to advance eye treatments
In a new study published in Stem Cell Reports, the Gamm Lab partnered with researchers at the Morgridge Institute for Research to develop lab-grown pig retinal organoids. They found that pig-derived photoreceptors shared many similarities with …
MERI-at-a-Glance (2025)
MERI-at-a-Glance 2025 Friday, February 21st, 2025; Discovery Building, DeLuca Forum Guest Speakers: Mohit Gupta (Computer Sciences) “Computer Vision, One Photon at a Time” Roomasa Channa (Ophthalmology & Visual Sciences) “Leveraging AI to decrease disparities in …
Sign up or donate to Cycle for Sight 2025!
Cycle for Sight 2025 kicks off at the Princeton Club West on Saturday, March 15th, with teams continuing to exercise in the community through April. You can register or donate to Cycle for Sight 2025 …
Congratulations to Prof. Krishanu Saha!
Congratulations to MERI PI and Retina Research Foundation Murphy Chair Prof. Krishanu Saha (WID, CoE, SMPH), who was recently named by STAT News as one of the 10 scientists who are moving CRISPR gene editing …
McPherson ERI Fall 2024 Insights is out!
In the new issue of InSights you can read about Dr. Roomasa Channa’s plan to ensure broader access to diabetic retinopathy care, and learn how Dr. Karen Schloss’s lab helps us make better decisions about …
New research in Nature Communications from the lab of MERI PI Raunak Sinha!
Congratulations to Raunak Sinha, the McPherson ERI’s David and Nancy Walsh Family Professor, for his group’s latest publication in Nature Communications! In their article, Saha et al. show that light adaptation, our visual system’s ability …
Gamm Lab Discoveries Culminate in FDA Approval of a Clinical Trial for the Treatment of Inherited Photoreceptor Diseases
BlueRock Therapeutics LP, a clinical stage cell therapy company and subsidiary of Bayer AG, today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for OpCT-001, …
Spring 2025 Seminar Series
Tuesday, January 14, 2025 – 3571 WIMR II Kimberly Edwards, Graduate Research Assistant (Cellular and Molecular Pathology, Waisman Center) Robust generation of photoreceptor-dominant retinal organoids from porcine induced pluripotent stem cells Andrew Miller, PhD, Postdoctoral …
Now on display in the Mandelbaum & Albert Family Vision Gallery: Constructs of Color Hard and Soft
As a fundamental aspect of human experience, color influences our perceptions, emotions, and interactions with the world around us. This exhibition – comprised of stained glass works by Randy Glysch and of fiber, needlework, and …